Coya Therapeutics, Inc.

COYA ·Healthcare, Drug Manufacturers - General, United States
Analysis › Moat Score

Moat Score — Coya Therapeutics, Inc.

Total Moat Score 4 / 30
Moat Factor Score Analysis
Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. 3 / 5 Proprietary Treg-focused biologic candidates plus Carnegie Mellon University-licensed exosome-targeting technology provide meaningful, though early-stage, intellectual property.
Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. 0 / 5 As a small clinical-stage biotech, Coya has no manufacturing or operating cost advantage versus larger, better-funded competitors.
Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. 0 / 5 With no approved products, Coya has no current pricing power; any future pricing power depends entirely on unproven clinical and regulatory success.
Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. 0 / 5 No network effects apply to a clinical-stage biopharmaceutical pipeline business.
Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. 0 / 5 No commercial product exists yet, so there are no customer switching costs to speak of.
Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. 1 / 5 The Treg-focused therapeutic niche has relatively few direct exosome-based competitors, offering a small measure of first-mover positioning if the mechanism proves out.